MEDBOX | Toolbox Public Health

Safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women

World Health Organization WHO (2021) C_WHO

COVID-19 Vaccines: 1 Safety Surveillance 2 Manual While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregnant women of reproductive age. As seen with non-pregnant women, a high proportion of pregnant women have asymptomatic SARS-CoV-2 infection and severe disease is associated with recognized medical (e.g., high body-mass index (BMI), diabetes, pre-existing pulmonary or cardiac conditions) and social (e.g., social deprivation, ethnicity) risk factors. Pregnant women with symptomatic COVID-19 appear to have an increased risk of intensive care unit admission, mechanical ventilation and death in comparison with non-pregnant women of reproductive age, although the absolute risks remain low. COVID-19 may increase the risk of preterm birth, compared with pregnant women without COVID-19, although the evidence is inconclusive

Tags: pregnant women, Pregnancy, Breastfeeding, COVID-19, Surveillance, safety, Vaccination,

Source: https://cdn.who.int/media/docs/default-s

Holistic response strategies for COVID-19

World Health Organization WHO (2020) C_WHO

This document outlines minimum requirements of laboratory testing for COVID-19 and link laboratory testing with surveillance and contact tracing to guide the outbreak response by national health authorities using a reduced number of tests performed. The strategies are organized according to stages of transmission: (‎1)‎ No cases reported or observed (‎Stage 0)‎; (‎2)‎ Imported cases (‎Stage 1)‎; (‎3)‎ Localized community transmission (‎Stage 2)‎; (‎4)‎ Large-scale community transmission (‎Stage 3)‎. For each stage, the recommended approaches indicate which testing strategy to prioritize when there are severe limitations on laboratory testing. The document is based on the current epidemiology of COVID-19 and available molecular testing methods

Tags: laboratory, COVID-19, laboratory tests,

Source: https://apps.who.int/iris/bitstream/hand

WHO toolkit for the care and support of people affected by complications associated with Zika virus

World Health Organization WHO (2017) C_WHO

The WHO Toolkit for the care and support of people affected by complications associated with Zika virus has been developed to serve as a model guide, with the goal of enhancing country preparedness for Zika virus outbreaks. The toolkit is intended to provide a systems approach involving public health planners and managers so that the necessary infrastructure and resources can be identified and incorporated as needed, as well as technical and practical guidance for health care professionals and community workers. The toolkit includes three manuals to provide countries with tools to effectively recognize people affected by Zika virus and deliver comprehensive care and support: Manual for public health planners and managers Manual for health care professionals Manual for community workers

Tags: care, caregivers, supportive care, Zika, guideline, preparedness, public health,

Source: https://apps.who.int/iris/bitstream/hand

Cadre conceptuel d’un plan national de suivi et de gestion de la résistance aux insecticides chez les vecteurs du paludisme

Organisation mondiale de la Santé (OMS) (2017) C_WHO

L’ampleur de la résistance aux insecticides chez les vecteurs du paludisme met en péril l’efficacité des programmes de lutte anti-vectorielle. Si cette résistance n’est pas atténuée, le taux de morbidité palustre va s’accroître, entraînant une hausse significative des coûts liés à la prévention de la maladie. Ce nouveau cadre est un guide pour l’élaboration d’un plan national de suivi et de gestion de la résistance aux insecticides chez les vecteurs du paludisme, lequel doit considéré comme partie intégrante du plan stratégique national de lutte contre le paludisme

Tags: monitoring and screening, vector management, insecticide resistance, malaria vectors, malaria control, malaria treatment, surveillance et dépistage, gestion des vecteurs, résistance aux insecticides, vecteurs du paludisme, contrôle du paludisme, traitement antipaludique,

Source: http://apps.who.int/iris/bitstream/handl

Framework for a national plan for monitoring and management of insecticide resistance in malaria vectors

World Health Organization (WHO) (2017) C_WHO

Effective malaria prevention is threatened by widespread and increasing vector insecticide resistance. Failure to mitigate this threat will likely result in an increased burden of disease, with significant cost implications. This new framework provides support for the development of a national insecticide resistance monitoring and management plan as part of a national malaria strategic plan

Tags: monitoring and screening, vector management, insecticide resistance, malaria vectors, malaria control, malaria treatment,

Source: http://apps.who.int/iris/bitstream/handl

Rapid Risk Assessment - Zika virus disease epidemic tenth update, 4 April 2017)

European Centre for Disease Prevention and Control (2017) CC

Tags: Guillain-Barrè Syndrome, Microcephaly, Zika, Assessment, sexual transmission,

Source: http://ecdc.europa.eu/en/publications/Pu

Zika virus country classification scheme

World Health Organization WHO (2017) C_WHO

Interim Guidance

Tags: classification, Surveillance, Zika,

Source: http://apps.who.int/iris/bitstream/10665

WHO's response to Zika virus and its associated complications - Report to donors, December 2016

World Health Organization WHO (2017) C_WHO

Tags: Zika, Epidemic Preparedness, rapid response,

Source: http://reliefweb.int/sites/reliefweb.int

Zika Strategic Response Plan Quarterly update, October 2016

World Health Organization WHO (2016) C_WHO

Tags: Zika, Strategic plan,

Source: http://www.who.int/emergencies/zika-viru

Zika Virus Research Agenda - October 2016

World Health Organization WHO (2016) C_WHO

Tags: Zika, research,

Source: http://apps.who.int/iris/bitstream/10665

	Safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women World Health Organization WHO (2021) C_WHO View PDF(6) Download (3) Add to my MEDBOX COVID-19 Vaccines: 1 Safety Surveillance 2 Manual While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregnant women of reproductive age. As seen with non-pregnant women, a high proportion of pregnant women have asymptomatic SARS-CoV-2 infection and severe disease is associated with recognized medical (e.g., high body-mass index (BMI), diabetes, pre-existing pulmonary or cardiac conditions) and social (e.g., social deprivation, ethnicity) risk factors. Pregnant women with symptomatic COVID-19 appear to have an increased risk of intensive care unit admission, mechanical ventilation and death in comparison with non-pregnant women of reproductive age, although the absolute risks remain low. COVID-19 may increase the risk of preterm birth, compared with pregnant women without COVID-19, although the evidence is inconclusive Tags: pregnant women, Pregnancy, Breastfeeding, COVID-19, Surveillance, safety, Vaccination, Source: https://cdn.who.int/media/docs/default-s
	Holistic response strategies for COVID-19 World Health Organization WHO (2020) C_WHO View PDF(23) Download (21) Add to my MEDBOX This document outlines minimum requirements of laboratory testing for COVID-19 and link laboratory testing with surveillance and contact tracing to guide the outbreak response by national health authorities using a reduced number of tests performed. The strategies are organized according to stages of transmission: (‎1)‎ No cases reported or observed (‎Stage 0)‎; (‎2)‎ Imported cases (‎Stage 1)‎; (‎3)‎ Localized community transmission (‎Stage 2)‎; (‎4)‎ Large-scale community transmission (‎Stage 3)‎. For each stage, the recommended approaches indicate which testing strategy to prioritize when there are severe limitations on laboratory testing. The document is based on the current epidemiology of COVID-19 and available molecular testing methods Tags: laboratory, COVID-19, laboratory tests, Source: https://apps.who.int/iris/bitstream/hand
	WHO toolkit for the care and support of people affected by complications associated with Zika virus World Health Organization WHO (2017) C_WHO View PDF(125) Download (71) Add to my MEDBOX The WHO Toolkit for the care and support of people affected by complications associated with Zika virus has been developed to serve as a model guide, with the goal of enhancing country preparedness for Zika virus outbreaks. The toolkit is intended to provide a systems approach involving public health planners and managers so that the necessary infrastructure and resources can be identified and incorporated as needed, as well as technical and practical guidance for health care professionals and community workers. The toolkit includes three manuals to provide countries with tools to effectively recognize people affected by Zika virus and deliver comprehensive care and support: Manual for public health planners and managers Manual for health care professionals Manual for community workers Tags: care, caregivers, supportive care, Zika, guideline, preparedness, public health, Source: https://apps.who.int/iris/bitstream/hand
	Cadre conceptuel d’un plan national de suivi et de gestion de la résistance aux insecticides chez les vecteurs du paludisme Organisation mondiale de la Santé (OMS) (2017) C_WHO View PDF(967) Download (371) Add to my MEDBOX L’ampleur de la résistance aux insecticides chez les vecteurs du paludisme met en péril l’efficacité des programmes de lutte anti-vectorielle. Si cette résistance n’est pas atténuée, le taux de morbidité palustre va s’accroître, entraînant une hausse significative des coûts liés à la prévention de la maladie. Ce nouveau cadre est un guide pour l’élaboration d’un plan national de suivi et de gestion de la résistance aux insecticides chez les vecteurs du paludisme, lequel doit considéré comme partie intégrante du plan stratégique national de lutte contre le paludisme Tags: monitoring and screening, vector management, insecticide resistance, malaria vectors, malaria control, malaria treatment, surveillance et dépistage, gestion des vecteurs, résistance aux insecticides, vecteurs du paludisme, contrôle du paludisme, traitement antipaludique, Source: http://apps.who.int/iris/bitstream/handl
	Framework for a national plan for monitoring and management of insecticide resistance in malaria vectors World Health Organization (WHO) (2017) C_WHO View PDF(1332) Download (341) Add to my MEDBOX Effective malaria prevention is threatened by widespread and increasing vector insecticide resistance. Failure to mitigate this threat will likely result in an increased burden of disease, with significant cost implications. This new framework provides support for the development of a national insecticide resistance monitoring and management plan as part of a national malaria strategic plan Tags: monitoring and screening, vector management, insecticide resistance, malaria vectors, malaria control, malaria treatment, Source: http://apps.who.int/iris/bitstream/handl
	Rapid Risk Assessment - Zika virus disease epidemic tenth update, 4 April 2017) European Centre for Disease Prevention and Control (2017) CC View PDF(1640) Download (525) Add to my MEDBOX Tags: Guillain-Barrè Syndrome, Microcephaly, Zika, Assessment, sexual transmission, Source: http://ecdc.europa.eu/en/publications/Pu
	Zika virus country classification scheme World Health Organization WHO (2017) C_WHO View PDF(1059) Download (360) Add to my MEDBOX Interim Guidance Tags: classification, Surveillance, Zika, Source: http://apps.who.int/iris/bitstream/10665
	WHO's response to Zika virus and its associated complications - Report to donors, December 2016 World Health Organization WHO (2017) C_WHO View PDF(1453) Download (516) Add to my MEDBOX Tags: Zika, Epidemic Preparedness, rapid response, Source: http://reliefweb.int/sites/reliefweb.int
	Zika Strategic Response Plan Quarterly update, October 2016 World Health Organization WHO (2016) C_WHO View PDF(961) Download (375) Add to my MEDBOX Tags: Zika, Strategic plan, Source: http://www.who.int/emergencies/zika-viru
	Zika Virus Research Agenda - October 2016 World Health Organization WHO (2016) C_WHO View PDF(1072) Download (553) Add to my MEDBOX Tags: Zika, research, Source: http://apps.who.int/iris/bitstream/10665

About MEDBOX

MEDBOX Video Series